Genedata Expressionist® enables biopharma to leverage the sensitivity and molecular insights provided by mass spectrometry for in-depth characterization and quality monitoring of RNA and oligonucleotide therapeutics.
![](/fileadmin/7.WhyGenedata/RNA_Therapies/EXP_Vial.png)
Flexible. Automated. Compliance-Ready.
The structural complexity and multistep production processes of oligonucleotide-based drugs require advanced MS analytical methods for in-depth characterization and stringent quality monitoring.
Genedata Expressionist® provides a flexible platform for streamlining MS data processing, analysis, and reporting throughout the development of RNA-based therapeutics, from early discovery to downstream regulated environments.
Customer Stories
![Bayer Logo Bayer Logo](/fileadmin/_processed_/7/f/csm_Bayer_286x160px_f0f20396ef.png)
Automating Therapeutic Oligonucleotide QC
"Genedata developed the end-to-end oligonucleotide QC data workflow and provided the consulting expertise throughout the entire project including the validation stage to help us achieve our goals on time and within budget."
![Merck Logo Roche Logo](/fileadmin/_processed_/1/e/csm_Roche_286x160px_04a3d91d45.png)
Automating MS-Based Analytics of Novel Therapeutic Oligos
"By reducing analysis time from 5–6 hours to less than 30 minutes per sample, Genedata Expressionist enabled us to overcome a major bottleneck in our analytical support of process development."